The effect of twice-daily aclidinium bromide on cough and sputum in patients with COPD: Results from phase III studies
ConclusionsAclidinium 400 µg BID may provide improvements in cough and sputum expectoration.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: McGarvey, L., Morice, A., Smith, J., Birring, S., Chuecos, F., Seoane, B., Jarreta, D. Tags: 5.1 Airway Pharmacology and Treatment Source Type: research
More News: Aclidinium Bromide | Chronic Obstructive Pulmonary | Cough | Drugs & Pharmacology | Respiratory Medicine | Spiriva | Study | Tiotropium